Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138‐week randomised studies of patients with osteoarthritis

OBJECTIVES: To assess the efficacy and safety of etoricoxib 60 mg once daily and naproxen 500 mg twice daily over a 138‐week treatment period in patients with osteoarthritis (OA). METHODS: Two 1‐year randomised, double blind, parallel group two‐part base studies (part I 12 weeks; part II 40 weeks),...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reginster, J Y, Malmstrom, K, Mehta, A, Bergman, G, Ko, A T, Curtis, S P, Reicin, A S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955093/
https://ncbi.nlm.nih.gov/pubmed/17142385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.059162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados